ILMN — Illumina Inc
NASDAQ · Life Sciences Tools & Services · Life Sciences Tools & Services
- Latest Close
- $125.44
- 30-Day Move
- -7.0%
- Market Cap
- $19.5B
- Shares Outstanding
- 152,900,000
- P/E Ratio
- 22.91
- P/B Ratio
- 7.55
Analyst consensus: Buy · 28 analysts
Illumina Inc
A read-only Alphactor snapshot forIllumina Inc. It uses the same research structure as the app, but with delayed data and shallow depth so search visitors can evaluate the stock before signing up.
Snapshot as of2026-04-23
Topline snapshot
Latest Close
$125.44
30-Day Move
-7.0%
Market Cap
$19.5B
Shares Outstanding
152,900,000
P/E Ratio
22.91
P/B Ratio
7.55
$125.44
-7.0%last 90 delayed daily bars
90D High
$155.53
90D Low
$112.65
Avg Volume
1,842,881
Gross margin is running at 66.6%, which gives a quick read on operating quality before you open the full model.
Net margin is 19.6%, useful for comparing ILMN against peers in Life Sciences Tools & Services.
ILMN is down 7.0% over the last 30 trading days shown on this page.
Latest operating income is $211M, which helps anchor the headline ratios with an actual earnings figure.
Composite Fair Value
$75.14
Rule of 40
20.8%
Latest Close
$125.44
30-Day Move
-7.0%
Market Cap
$19.5B
Shares Outstanding
152,900,000
P/E Ratio
22.91
P/B Ratio
7.55
ROE
31.2%
ROA
12.8%
Gross Margin
66.6%
Operating Margin
18.4%
Net Margin
19.6%
Debt / Equity
0.73
Current Ratio
2.08
Latest Revenue
$1.2B
Revenue
$1.2B
Gross Profit
$759M
Operating Income
$211M
Net Income
$334M
Gross Margin
6661.0%
Net Margin
1957.0%
Current Ratio
2.08
Debt / Equity
0.73
Fair Value
$75.14
Upside / Downside
-40.1%
Signal
Overvalued
Implied Growth
6.3%
DCF
$74.64
EPV
$16.17
EV/Rev
$134.60
Growth Assumption
-1.8%
Discount Rate
8.4%
Terminal Growth
2.0%
Base FCF
$931M
Valuation spread
After signup
The full valuation workspace goes deeper
Adjust DCF growth, discount, and terminal assumptions instead of relying on one static snapshot.
Open the deeper balance-sheet and cash-flow views to inspect debt, liquidity, and cash generation line by line.
Compare multiple valuation models against peers and save your own thesis instead of re-reading a fixed public state.
Low growth priced in
Altman Z
4.26
Safe
Piotroski
8
Strong (7-9)
Cash Conversion
1.27x
Rule of 40
20.8%
Concerning
Annual performance mix
| Period | Revenue | Operating Income | Net Income | Free Cash Flow |
|---|---|---|---|---|
| 2022-12-31 | $4.6B | $354M | $-4.4B | $106M |
| 2023-12-31 | $4.5B | $-222M | $-1.2B | $283M |
| 2024-12-31 | $4.4B | $600M | $-1.2B | $709M |
| 2025-12-31 | $4.3B | $817M | $850M | $931M |
After signup
The app opens the full statement deep dive
Extend the history well beyond this public snapshot to inspect longer cycles and regime changes.
Move from summary lines into detailed balance-sheet and cash-flow rows for working capital, debt, and capex analysis.
Cross-link statement changes with alerts, watchlists, and saved research workflows after signup.
After signup
The full sentiment workspace adds context
Go past the public headlines into fuller article history, source cross-checks, and deeper narrative tracking.
Tie news into alerts, watchlists, and conviction changes instead of browsing one static batch of stories.
| ETF | Shares | Weight | As Of |
|---|---|---|---|
| GROWTH FUND OF AMERICA | 6,214,926 | 0.04% | 2025-12-31 |
| iShares Trust-iShares Core S&P Mid-Cap ETF | 4,935,847 | 0.03% | 2026-02-28 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 4,562,507 | 0.03% | 2025-12-31 |
| AMERICAN BALANCED FUND | 3,587,275 | 0.02% | 2026-03-31 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 3,294,131 | 0.02% | 2025-12-31 |
| NEW ECONOMY FUND | 2,668,036 | 0.02% | 2025-12-31 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Value Index Fund | 2,123,894 | 0.01% | 2025-12-31 |
| WASHINGTON MUTUAL INVESTORS FUND | 1,900,000 | 0.01% | 2026-03-31 |
After signup
The deeper ownership view shows who is leaning in
Open richer institutional and holder diffs to see position changes across filings instead of one static snapshot.
Use those ownership shifts alongside conviction and alerts in the full app workflow.
BlackRock
Filed 2024-05-10
$1.9B
--
Vanguard Group
Filed 2026-01-29
$1.9B
-1.9%
Geode Capital Management
Filed 2026-02-09
$375M
+4.8%
Invesco
Filed 2026-02-19
$360M
+97.0%
Citadel Advisors
Filed 2025-08-14
$251M
--
FMR LLC (Fidelity)
Filed 2026-02-17
$222M
+7.9%
3.68
Consensus
Buy—
—
—
28
For informational and educational purposes only. Not financial advice. Learn more
Related reading
Research and strategy guides from the alphactor blog.
Accruals Quality: How to Spot Earnings That Aren't Real
Accruals measure the gap between reported earnings and actual cash. Widening accruals is one of the most reliable red flags in financial analysis — Sloan's…
Altman Z-Score: A Bankruptcy Predictor That Still Works
Edward Altman's 1968 discriminant model predicts bankruptcy within two years about 72% of the time at its distress threshold.
Balance Sheet Deep Dive
Balance sheet changes lead income statements by 2-6 quarters. Net debt, receivables days, and goodwill are the lines that move stocks first.